Utility of a Novel Mobile Lip‐Reading Application for Patients After Total Laryngectomy
Total laryngectomy (TL) patients have limited options for speech rehabilitation in the immediate postoperative period, resulting in communication difficulties and patient frustration. This study investigates a novel mobile application (app), Speech Recognition Application for the Voice Impaired (SRAVI), to improve postoperative communication for TL patients. Participants received a tutorial on the technology prior to use and had access to the app throughout their hospital admission. A total of 16 patients were included. Of 652 valid transactions within the app, accurate phrase return on the first attempt was 43% with a total accuracy of 67%. Patients used SRAVI primarily to communicate with their care team (66.7%) and with family members/social support (80%). Patients reported using SRAVI, on average, 43.6% of the time to communicate during their hospitalization the majority (69.7%) preferred SRAVI to written communication. In TL patients, use of speech recognition technology is feasible in the immediate postoperative period.
Authors
- Robert J. Sinard (ORCID: https://orcid.org/0000-0001-9348-2165)
- James L. Netterville (ORCID: https://orcid.org/0000-0002-7282-8769)
- Michael C. Topf (ORCID: https://orcid.org/0000-0002-1022-4417)
- Sarah L. Rohde (ORCID: https://orcid.org/0000-0003-4353-5745)
- Alexander Langerman (ORCID: https://orcid.org/0000-0003-0866-463X)
- Shreyas G. Krishnapura (ORCID: https://orcid.org/0000-0002-1486-5625)
- Daniel Sharbel
- Kyle Mannion (ORCID: https://orcid.org/0000-0001-9391-1791)
- Eben Lloyd Rosenthal (ORCID: https://orcid.org/0000-0003-0294-5203)
- C. A. Fassler
Institutions
- Vanderbilt University (US)
- Augusta University (US)
- Augusta University Health (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Otolaryngology
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1002/ohn.70098
- Primary Topic
- Voice and Speech Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vanderbilt University
- National Cancer Institute